Concepedia

Author

Graeme Currie

Rainier Clinical Research Center

Also Known As

G. Currie, G.M. Currie, Graeme Currie

20

Publications

1.3K

Citations

9

H-Index

24

Concepts

All Affiliations

Rainier Clinical Research CenterGilead Sciences (United States)The University of Texas MD Anderson Cancer CenterEuropean Institute of OncologyCity of Hope
GC

About

Graeme Currie is an author at Rainier Clinical Research Center specializing in medicine, urology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

248

2

Health Sciences

2

2

107

3

Immunology

2

2

107

4

Hepatology

1

1

23

5

Pathology

1

1

24

Graeme Currie

×

8

Publications

1.2K

Citations

8

H-Index

YearCitations

Long-Term Therapy with Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B

Stephanos J. Hadziyannis, Nicolaos C. Tassopoulos, E. Jenny Heathcote,

New England Journal of Medicine

2005

535

Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B

Karsten Wursthorn, Marc Lütgehetmann, Maura Dandri,

Hepatology

2006

438

Safety and efficacy of adefovir dipivoxil in patients infected with lamivudine-resistant hepatitis B and HIV-1

Yves Benhamou, Vincent Thibault, Pamela Vig,

Journal of Hepatology

2005

81

FIERCE-22: Clinical activity of vofatamab (V) a FGFR3 selective inhibitor in combination with pembrolizumab (P) in WT metastatic urothelial carcinoma, preliminary analysis.

Arlene O. Siefker‐Radtke, Graeme Currie, Esteban Abella,

Journal of Clinical Oncology

2019

64

Fierce-21: Phase II study of vofatmab (B-701), a selective inhibitor of FGFR3, as salvage therapy in metastatic urothelial carcinoma (mUC).

Andrea Necchi, Daniel Castellano, Begoña Mellado,

Journal of Clinical Oncology

2019

43

FIERCE-21: Phase 1b/2 study of docetaxel + b-701, a selective inhibitor of FGFR3, in relapsed or refractory (R/R) metastatic urothelial carcinoma (mUCC).

Joaquim Bellmunt, Joel Picus, Manish Kohli,

Journal of Clinical Oncology

2018

24

Dosing guidelines for Adefovir Dipivoxil in the treatment of HBV infected patients with renal or hepatic impairment

W B Knight, Sandra Hayashi, Yves Benhamou,

Journal of Hepatology

2002

23

Clinical activity of vofatamab (V), an FGFR3 selective antibody in combination with pembrolizumab (P) in metastatic urothelial carcinoma (mUC), updated interim analysis of FIERCE-22

Arlene O. Siefker‐Radtke, Krzysztof Tupikowski, Zoran Andrić,

Annals of Oncology

2019

13

Page 1